A Screening Strategy Based on Differential Binding of Ligand to Receptor and to Binding Proteins: Screening for Compounds Interacting with Corticotrophin-Releasing Factor-Binding Protein
Free accessResearch articleFirst published online December, 1999
A Screening Strategy Based on Differential Binding of Ligand to Receptor and to Binding Proteins: Screening for Compounds Interacting with Corticotrophin-Releasing Factor-Binding Protein
The ligand-receptor interaction has been commonly used in development of high throughput screening assays for new drugs. In some cases, an endogenous ligand interacts not only with membrane receptors but also with soluble binding proteins. Corticotrophin-releasing factor (CRF) is an important stress neurotransmitter/hormone involved in both the central and peripheral nervous systems. CRF exerts its function by interacting with CRFR1 and CRFR2 receptors. In addition, CRF-binding protein (CRF-BP) binds CRF with high affinity. Accordingly, CRF-BP has been suggested to play an important role in modulating CRF function. Based on the potential involvement of CRF-BP in many neurological disorders, it is desirable to develop a screening assay to look for drugs that either mimic or interfere with CRF binding to CRF-BP. An assay was developed to monitor the interactions of radiolabeled CRF with human/rat CRF-BP and the mouse CRFR1 (mCRFR1) receptor. By carefully examining the binding characteristics of radiolabeled CRF to mCRFR1, the assay was able to identify compounds that bind to CRF-BP with high affinity and have little or no affinity for mCRFR1 receptors. Based on a mathematical model, we have verified the screening system with several well-characterized CRF ligands that all have different affinities for CRF receptors and CRF-BP.
References
1.
Antoni, F.A. (1986). Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev.7:351-370.
2.
Chalmers, D., Lovenberg, T., Grigoriadis, D., Behan, D., De Souza, E. (1996). Corticotrophin-releasing factor receptors: From molecular biology to drug design. Trends Pharmacol. Sci.17:166-172.
3.
Chen, R., Lewis, K.A., Perrin, M.H., Vale, W.W. (1993). Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. U.S.A.90:8967-8971.
4.
Vita, N., Laurent, P., Lefort, S., Chalon, P., Lelias, J., Kaghad, M., Fur, G.L., Caput, D., Ferrara, P. (1993). Primary structure and functional expression of mouse pituitary and human brain corticotropin releasing factor receptors. FEBS Lett.335:1-5.
5.
Chang, C.P., Pearse, R.V., 2nd, O'Connell, S., Rosenfeld, M.G. (1993). Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron11:1187-1195.
6.
Perrin, M.H., Donaldson, C.J., Chen, R., Lewis, K.A., Vale, W.W. (1993). Cloning and functional expression of a rat brain corticotrophin releasing factor (CRF) receptor. Endocrinology133:3058-3061.
7.
Lovenberg, T., Liaw, C., Grigoriadis, D., Clevenger, W., Chalmers, D., De Souza, E., Oltersdorf, T. (1995). Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A.92:836-840.
8.
Perrin, M., Donaldson, C., Chen, R., Blount, A., Berggren, T., Bilezikjian, L., Sawchenko, P., Vale, W. (1995). Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. U.S.A.92:2969-2973.
9.
Kishimoto, T., Pearse, R.V., 2nd, Lin, C.R., Rosenfeld, M.G. (1995). A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. U.S.A.92:1108-1112.
10.
Stenzel, P., Kesterson, R., Yeung, W., Cone, R.D., Rittenberg, M.B., Stenzel Poore, M.P. (1995). Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol. Endocrinol.9:637-645.
11.
Orth, D.N., Mount, C.D. (1987). Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem. Biophys. Res. Common.143:411-417.
12.
Suda, T., Sumitomo, T., Tozawa, F., Ushiyama, T., Demura, H. (1989). Corticotropin-releasing factor-binding protein is a glycoprotein. Biochem. Biophys. Res. Common.165:703-707.
13.
Sutton, S.W., Behan, D.P., Lahrichi, S.L., Kaiser, R., Corrigan, A., Lowry, P., Potter, E., Perrin, M.H., Rivier, J., Vale, W.W. (1995). Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology136:1097-1102.
14.
Potter, E., Behan, D., Fischer, W., Linton, E., Lowry, P., Vale, W. (1991). Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature349:423-426.
15.
Cortright, D.N., Nicoletti, A., Seasholtz, A.F. (1995). Molecular and biochemical characterization of the mouse brain corticotropin-releasing hormone-binding protein. Mol. Cell. Endocrinol.111:147-157.
16.
Perkins, A.V., Eben, F., Wolfe, C.D., Schulte, H.M., Linton, E.A.S.O. (1993). Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy. J. Endocrinol.138:149-157.
17.
Saphier, P.W., Faria, M., Grossman, A., Coy, D.H., Besser, G.M., Hodson, B., Parkes, M., Linton, E.A., Lowry, P.J. (1992). A comparison of the clearance of ovine and human corticotropin-releasing hormone in man and sheep: A possible role for CRF-binding protein. J. Endocrinol.133:487-495.
18.
De Souza, E., Whitehouse, P., Kuhar, M., Price, D., Vale, W. (1986). Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature319:593-595.
19.
Chung, F.Z., Wu, L.H., Vartanian, M.A., Watling, K.J., Guard, S., Woodruff, G.N., Oxender, D.L. (1994). The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors. Biochem. Biophys. Res. Commun.198:967-972.
20.
Perrin, M.H., Haas, Y., Rivier, J.E., & Vale, W.W. (1986). Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides. Endocrinology118:1171-1179.
21.
Wynn, P., Aguilera, G., Morell, J., Catt, K. (1983). Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor. Biochem. Biophys. Res. Common.110:602-608.
22.
Webster, E.L., De Souza, E.B. (1988). Corticotropin-releasing factor receptors in mouse spleen: Identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides. Endocrinology122:609-617.
23.
Wells, J.W. (1992). Analysis and interpretation of binding at equilibrium. In Receptor-Ligand Interaction—A Practical Approach. E.C. Hulme (ed.), pp. 311-316. IRL Press, City.
24.
Gulyas, J., Rivier, C., Perrin, M., Koerber, S.C., Sutton, S., Corrigan, A., Lahrichi, S.L., Craig, A.G., Vale, W., Rivier, J. (1995). Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl. Acad. Sci. U.S.A.92:10575-10579.
25.
Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M.H., Lewis, K., Sutton, S., Chan, R., Turnbull, A.V., Lovejoy, D., Rivier, C., et al. (1959). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor [see comments]. Nature378:287-292.
26.
Takahashi, Z., Totsune, K., Sone, M., Murakami, O., Satoh, F., Anihara, Z., Sasano, H., Ilno, K., Mouri, T. (1998). Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides19:643-647.
27.
Donaldson, C.J., Sutton, S.W., Perrin, M.H., Corrigan, A.Z., Lewis, K.A., Rivier, J.E., Vaughan, J.M., Vale, W.W. (1996). Cloning and characterization of human urocortin. Endocrinology137:2167-2170.
